Mendaera's vision is to digitize clinical judgment and technical expertise, making high-quality care available for every patient at every care facility. Its platform in development combines robotics, AI, real-time imaging, and connectivity, to enable intervention at scale. Mendaera's robotic system has not been cleared by the FDA for sale in the United States.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/26/24 | $73,000,000 | Series B |
Fred Moll Lux Capital PFM Health Sciences Threshold Ventures  | undisclosed |
